Look up the current record

Heard about a peptide? Get the current.

Search the name people are using. PepCurrent will show the human evidence, the FDA record, the risks and unknowns—and the part the post left out.

Popular now Reta BPC-157 Ozempic The tanning one MK-677 A–Z →

Fast answer, full receipts. Evidence files report the record. They do not recommend a compound, protocol, vendor, or personal decision. How PepCurrent checks claims →

Dated change feed

What changed. What did not.

This is the moving record: source-checked FDA events, evidence audits, and explainers. Dates describe the public record—not when a trend became popular.

FDA Tracker · Last checked July 25, 2026

The committee votes are complete. FDA’s final action is not.

The Pharmacy Compounding Advisory Committee recorded fourteen form-specific votes across seven peptide groups. The advisory recommendations did not approve a drug or make a final 503A Bulks List determination.

Open the FDA Tracker → Read the July brief

Jul 25, 2026Field guideAn advisory “yes” is not FDA approval. Here is the decision path. Jul 18, 2026Milestone DecoderThe Word After Phase 3 Is Not “Approved” Jul 18, 2026Peptide ScienceWhat 544 BPC-157 Papers Become in Humans May 11, 2026Issue 01BPC-157 was not “legalized.” Here is what changed.

Open the Reading Room → Follow the RSS record →

Heard about a peptide? Get the current.

The committee votes are complete. FDA’s final action is not.

Get the useful changes, with the receipts attached.